<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today




The Union Ministry of Ayush, led by Goa's Sripad Naik claimed that Homeopathic drug Arsenicum album 30 was a palliative for COVID-19.

There is no empirical evidence to prove that Arsenic Album 30 can be used as a palliative for Covid-19.

There is no empirical evidence to prove that Arsenic Album 30 can be used as a palliative for Covid-19.The Ministry of AYUSH of India had released an advisory on 29 Jan 2020 which stated that the Central Council for Research in Homoeopathy (CCRH) at the instance of Ministry of AYUSH discussed the ways and means of prevention of Coronavirus and suggested that Arsenicum album 30 could be taken as a prophylactic medicine against Coronavirus infection.

Further, Central Council for Research in Homeopathy, in its report had stated that Arsenicum album-30 can be used as a preventive measure only for flu-like illness, which is a common prescription in cases of respiratory infections such as fever, cough, runny nose, sore throat, and headache in day to day practice.

Also, Sripad Naik's claim that Arsenic Album 30 was a palliative for COVID-19 is not scientifically proven. There are no studies within the evidence-based framework that suggests the use of Arsenicum album 30 for coronavirus infection.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day


397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.